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Preparation of Apt-AuNS nanoconstructs:
The synthesis of Apt-AuNS was performed as previously reported. 1 AS1411 aptamer with a disulfide modification at the 5'-end (5'-T-(C6-S-S-C6)-TTG GTG GTG GTG GTT GTG GTG GTG GTG G-3') was purchased from IDT DNA, Inc. HPLC-purified aptamers were dissolved in Millipore water (18.2 MΩ cm) to obtain 1 mM solutions. The disulfide bond was cleaved by adding 2.5 µL of 25 mM tris(2-carboxyethyl) phosphine (TCEP) (Sigma Aldrich) to 10 µL of the 1 mM aptamer solution. After 30 min, the thiolated aptamer solution was added to 10 mL of 0.19 nM AuNS and left overnight to form the nanoconstruct (Apt-AuNS). To increase the surface concentration of aptamers on AuNS, we salted the mixture solution with 2.5 mL of a 500 mM solution of NaCl twice, separated by 4 h.
Quantifying number of AS1411 strands on AuNS: Cy5-labeled aptamer 5'-(C6-S-S-C6)-Cy5-TTG GTG GTG GTG GTT GTG GTG GTG GTG G-3' (Cy5-Apt) was used to estimate the number of aptamers on each particle. Attachment of Cy5-Apt to the AuNS followed the same procedure as described previously. We centrifuged 200 µL of Cy5-labeled Apt-AuNS (Cy5-Apt-AuNS) at 15,000 rpm for 11 min. The supernatant was removed, and the nanoconstructs were suspended in 1 mL of 50 mM HEPES buffer. This process was repeated twice to eliminate unbound Cy5-Apt. Cy5-Apt-AuNS pellets were treated with 100 µL of 20 mM potassium cyanide (KCN) overnight to dissolve the Au core of the nanoconstruct and release Cy5 aptamer into the solution. The Cy5 fluorescence intensity of the KCN solution was measured using a NanoDrop Spectrophotometer, and the concentration of AS1411 was determined based on the intensity of the Cy5 signal. This fluorescent assay indicated that approximately 110 strands of AS1411 were conjugated on a single AuNS.
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Immunoblotting of nucleolin: Cancer and normal cells were harvested from cell culture flasks.
To determine expression of cytosolic nucleolin in cancer and normal cells, we lysed the cells on ice for 15 min in 5% NP40 lysis buffer (Invitrogen), followed by centrifugation at 10,000 g for 20 min. The supernatant contained the cytosolic extract, and the pellet contained the nuclear components.
For plasma membrane extraction, cancer and normal cells were lysed in Homogenize Buffer (Abcam) and homogenized 50 times on ice using a Dounce homogenizer. The nuclei were removed by centrifugation at 700 g for 10 min at 4 °C. The supernatant was centrifuged at 10,000 g for 30 min at 4 °C. After centrifugation, the new supernatant containing the cytosol fraction was removed. The pellet containing the total cellular membranes was purified to isolate further the plasma membranes from other organelle membranes. The total cellular membrane pellet was re-suspended in mixture of Lower Phase and Upper Phase solutions (Abcam). The solution was centrifuged at 1,000 g for 5 min at 4 °C. The upper phase was collected and diluted with nuclease free water (Invitrogen). The diluted solution was centrifuged at 21,000 g for 20 min at 4 °C. The resultant pellet contained the plasma membrane proteins.
Protein concentrations after the extractions were determined by the Bradford assay (Pierce).
Aliquots of the cytosolic extracts containing 20 µg of protein were electrophoresed on a 10%
Tris-HCl gel (Bio Rad) and transblotted using PVDF membranes (Millipore). Antihuman 
